Metformin Hydrochloride Extended-Release Tablets

FDA Drug Profile — Metformin Hydrochloride

Metformin Hydrochloride Extended-Release Tablets is listed in the FDA National Drug Code directory with 8 NDC codes, marketed under brand name including Metformin Hydrochloride. Available dosage form: tablet, film coated, extended release.

Drug details

Generic Name
Metformin Hydrochloride Extended-Release Tablets
Brand Names
Metformin Hydrochloride
Application Number
ANDA209993
Sponsor
AiPing Pharmaceutical, Inc.
NDC Codes
8
Dosage Forms
TABLET, FILM COATED, EXTENDED RELEASE
Routes
ORAL
Active Ingredients
METFORMIN HYDROCHLORIDE

Indications and Usage

1 INDICATIONS AND USAGE Metformin hydrochloride extended-release tablets are indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus. Metformin hydrochloride extended-release tablets are biguanide indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus. (1)

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.